In its newly launched Investment Case for Vaccine-Preventable Disease Surveillance in the African Region 2020-2030, the World Health Organization (WHO) Regional Office for Africa highlights the drastic consequences that could be in store for the region if countries do not invest in disease surveillance efforts, including a US$22.4 billion economic burden over the next decade.